Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-diabetic drugs of the thiazolidinedione (TZD) structural class as well as α-lipoic acid activate peroxisome proliferator-activated receptor γ (PPARγ), a nuclear transcription factor that controls glucose metabolism and lipid homeostasis. CAY10506 is a hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 μM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $1,230 | 35 days | 35 days |
| Description | Anti-diabetic drugs of the thiazolidinedione (TZD) structural class as well as α-lipoic acid activate peroxisome proliferator-activated receptor γ (PPARγ), a nuclear transcription factor that controls glucose metabolism and lipid homeostasis. CAY10506 is a hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 μM. |
| Synonyms | CAY10506 |
| Molecular Weight | 454.63 |
| Formula | C20H26N2O4S3 |
| Cas No. | 292615-75-9 |
| Relative Density. | 1.305 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol: 3 mg/mL (6.6 mM), Sonication is recommended. DMF: 5 mg/mL (11 mM), Sonication is recommended. DMSO:PBS(pH 7.2) (1:5): 0.15 mg/mL (0.33 mM), Sonication is recommended. DMSO: 5 mg/mL (11 mM), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.